Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 22411928)

1.

Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease.

Smith ER, Tomlinson LA, Ford ML, McMahon LP, Rajkumar C, Holt SG.

Hypertension. 2012 May;59(5):973-8. doi: 10.1161/HYPERTENSIONAHA.111.187807. Epub 2012 Mar 12.

2.

Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.

Kyriazis J, Tzanakis I, Stylianou K, Katsipi I, Moisiadis D, Papadaki A, Mavroeidi V, Kagia S, Karkavitsas N, Daphnis E.

Nephrol Dial Transplant. 2011 Sep;26(9):2971-7. doi: 10.1093/ndt/gfq847. Epub 2011 Mar 21.

3.

Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4.

Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG.

Hypertension. 2010 May;55(5):1110-5. doi: 10.1161/HYPERTENSIONAHA.109.143024. Epub 2010 Mar 8.

4.

Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study.

Utescu MS, Couture V, Mac-Way F, De Serres SA, Marquis K, Larivière R, Desmeules S, Lebel M, Boutouyrie P, Agharazii M.

Hypertension. 2013 Jul;62(1):154-60. doi: 10.1161/HYPERTENSIONAHA.113.01200. Epub 2013 May 6.

5.

Impact of aortic stiffness on survival in end-stage renal disease.

Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM.

Circulation. 1999 May 11;99(18):2434-9.

6.

Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.

Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB.

Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):372. Epub 2004 Nov 18. Erratum in: Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):875. Pusalkar, Pusalkar [corrected to Pawan, Pusalkar].

7.

Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.

Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, Laurent S, Boutouyrie P, Briet M; Nephro Test Study Group.

Hypertension. 2012 Dec;60(6):1451-7. doi: 10.1161/HYPERTENSIONAHA.112.197210. Epub 2012 Oct 22.

8.

Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised?

Covic A, Mardare N, Gusbeth-Tatomir P, Prisada O, Sascau R, Goldsmith DJ.

Nephrol Dial Transplant. 2006 Oct;21(10):2859-66. Epub 2006 Jul 19.

9.

Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.

Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW.

Nephron Clin Pract. 2007;107(4):c177-81. Epub 2007 Nov 1.

PMID:
17975325
10.

Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.

Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM.

Nephrol Dial Transplant. 2006 May;21(5):1293-9. Epub 2006 Jan 5.

11.

Aortic stiffness and central wave reflections predict outcome in renal transplant recipients.

Verbeke F, Maréchal C, Van Laecke S, Van Biesen W, Devuyst O, Van Bortel LM, Jadoul M, Vanholder R.

Hypertension. 2011 Nov;58(5):833-8. doi: 10.1161/HYPERTENSIONAHA.111.176594. Epub 2011 Sep 6.

12.

Cognitive impairment and 7-year mortality in dialysis patients.

Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP.

Am J Kidney Dis. 2010 Oct;56(4):693-703. doi: 10.1053/j.ajkd.2010.07.003. Epub 2010 Aug 25.

PMID:
20800327
13.

Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis.

LeBoeuf A, Mac-Way F, Utescu MS, De Serres SA, Douville P, Desmeules S, Lebel M, Agharazii M.

Nephrol Dial Transplant. 2011 Nov;26(11):3695-701. doi: 10.1093/ndt/gfr138. Epub 2011 Mar 31.

14.
15.

Serum phosphate levels and mortality risk among people with chronic kidney disease.

Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL.

J Am Soc Nephrol. 2005 Feb;16(2):520-8. Epub 2004 Dec 22.

16.

Pulse wave velocity and vascular calcification at different stages of chronic kidney disease.

Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I, Presne C, Makdassi R, Andrejak M, Tribouilloy C, Galan P, Safar ME, Choukroun G, Massy Z.

J Hypertens. 2010 Jan;28(1):163-9. doi: 10.1097/HJH.0b013e328331b81e.

PMID:
19927012
18.

Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.

Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE.

Nephrol Dial Transplant. 2006 May;21(5):1257-62. Epub 2006 Jan 18.

19.

Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.

Chue CD, Edwards NC, Davis LJ, Steeds RP, Townend JN, Ferro CJ.

Nephrol Dial Transplant. 2011 Aug;26(8):2576-82. doi: 10.1093/ndt/gfq787. Epub 2011 Jan 19.

20.

The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.

Phelan PJ, O'Kelly P, Walshe JJ, Conlon PJ.

Ren Fail. 2008;30(4):423-9. doi: 10.1080/08860220801964236.

PMID:
18569917
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk